Abstract:The pro‐inflammatory cytokine IL‐1β could be triggered and released from macrophages (Mφ) by lactate derived from tumor cells. Interleukin (IL)‐1β, in turn, drove an immune inhibitory phenotype on tumor cells, especially on the increase in programmed death‐ligand 1, by activating the nuclear factor‐κB (NF‐κB) signaling pathway. Thus, tumor‐released lactate and Mφ‐derived IL‐1β mediated the crosstalk loop and caused immunosuppression. Moreover, activated NF‐κB signaling promoted C‐C motif chemokine ligand 2 secretion in tumor cells, leading to further monocyte recruitment and replenishment of the Mφ population, which maintained the malignant feedback loop (Figure 7). Tumor‐associated macrophages (TAMs) play critical roles in reprogramming other immune cells and orchestrating antitumor immunity. However, the interplay between TAMs and tumor cells responsible for enhancing immune evasion remains insufficiently understood. Here, we revealed that interleukin (IL)‐1β was among the most abundant cytokines within the in vitro tumor‐macrophage coculture system, and enhanced IL‐1β expression was associated with impaired cytotoxicity of CD8+ T cells in human ovarian cancer, indicating the possibility that IL‐1β mediated immunosuppression during tumor‐TAMs crosstalk. Mechanistically, we demonstrated that IL‐1β significantly boosted programmed death‐ligand 1 (PD‐L1) expression in tumor cells via the activation of the nuclear factor‐κb signaling cascade. Specifically, IL‐1β released from TAMs was triggered by lactate, the anaerobic metabolite of tumor cells, in an inflammasome activation‐dependent manner. IL‐1β sustained and intensified immunosuppression by promoting C‐C motif chemokine ligand 2 secretion in tumor cells to fuel TAMs recruitment. Importantly, IL‐1β neutralizing antibody significantly curbed tumor growth and displayed synergistic antitumor efficacies with anti‐PD‐L1 antibody in tumor‐bearing mouse models. Together, this study presents an IL‐1β‐centered immunosuppressive loop between TAMs and tumor cells, highlighting IL‐1β as a candidate therapeutic target to reverse immunosuppression and potentiate immune checkpoint blockade.

FoxO1 is a Regulator of MHC-II Expression and Anti-Tumor Effect of Tumor-Associated Macrophages

FOXN Transcription Factors: Regulation and Significant Role in Cancer

FOXN Transcription Factors: Regulation and Significant Role in Cancer.

Hepatocellular carcinoma-derived FOXO1 inhibits tumor progression by suppressing IL-6 secretion from macrophages

Multi-omics analysis identifies FoxO1 as a regulator of macrophage function through metabolic reprogramming

The Essential Role of FoxO1 in the Regulation of Macrophage Function

Blockade of C5a Receptor Unleashes Tumor-Associated Macrophage Antitumor Response and Enhances CXCL9-dependent CD8+ T Cell Activity

Mir-182 Targeting Reprograms Tumor-Associated Macrophages and Limits Breast Cancer Progression

Targeting immune checkpoints on tumor-associated macrophages in tumor immunotherapy.

Retraction Note To: FoxM1 Down-Regulation Leads to Inhibition of Proliferation, Migration and Invasion of Breast Cancer Cells Through the Modulation of Extra-Cellular Matrix Degrading Factors

Transcription factor Zhx2 is a checkpoint that programs macrophage polarization and antitumor response

Aberrantly high activation of a FoxM1–STMN1 axis contributes to progression and tumorigenesis in FoxM1-driven cancers

The TNF-α/ROS/HIF-1-induced upregulation of FoxMI expression promotes HCC proliferation and resistance to apoptosis.

FOXM1 derived from Triple negative breast cancer exosomes promotes cancer progression by activating IDO1 transcription in macrophages to suppress ferroptosis and induce M2 polarization of Tumor-associated macrophages

Mechanisms Controlling the Anti-Neoplastic Functions of FoxO Proteins.

LAMTOR1 Phosphorylation of Exo70 Facilitates Tumor-Associated Macrophage Polarization to Restrain CD8+ T Cell Function in HCC

Research Progress on the Role of FOXOs Family in Cancer

FOXK Transcription Factors: Regulation and Critical Role in Cancer

FBXO38 Regulates Macrophage Polarization to Control the Development of Cancer and Colitis

An extensive analysis of the prognostic and immune role of FOXO1 in various types of cancer

Macrophages facilitate tumor cell PD‐L1 expression via an IL‐1β‐centered loop to attenuate immune checkpoint blockade